Aspiration biopsy in the context of the new Medicare fiscal policy.

Abstract

The new Medicare legislation requires hospital reimbursement on a per case, rather than cost per test, basis. This policy emphasizes selectivity in hospitalization, increased efficiency in diagnosis and therapy and abbreviated hospital stays. Aspiration biopsy is discussed as a procedure that responds to needs stimulated by fiscal demands, with particular attention given to cost containment and outpatient care and aspiration biopsy's value as a vehicle that ensures high-quality medical care.